What the Label Doesn't Cover: Analytical Realities of Gray-Market Modafinil and the Limits of 'Pharmaceutical-Grade' Claims
Online modafinil sellers often promise pharmaceutical-grade quality, but unregulated supply chains offer no reliable release specification. This article examines adulteration, variable dosing, US enforcement realities, and harm-reduction considerations for clinicians confronting gray-market use.